NOC director logs stock sales around $560 under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Northrop Grumman Corporation (NOC) reported insider activity by a director, who filed a Form 4 disclosing multiple open-market sales of common stock on 11/24/2025. The transactions were sales of very small share amounts, with prices ranging from about $560.39 to $566.15 per share. All sales are marked as dispositions and were made in the open market.
The director conducted these trades under a pre-established Rule 10b5-1 trading plan adopted on August 23, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following these transactions, the reporting person directly beneficially owns 4,281 shares of Northrop Grumman common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 97 shares ($54,716)
Net Sell
7 txns
Insider
WELSH MARK A III
Role
Director
Sold
97 shs ($55K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1 | $560.39 | $560.39 |
| Sale | Common Stock | 6 | $561.51 | $3K |
| Sale | Common Stock | 7 | $562.52 | $4K |
| Sale | Common Stock | 9 | $563.62 | $5K |
| Sale | Common Stock | 61 | $564.36 | $34K |
| Sale | Common Stock | 12 | $565.31 | $7K |
| Sale | Common Stock | 1 | $566.15 | $566.15 |
Holdings After Transaction:
Common Stock — 4,377 shares (Direct)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025. Represents the weighted average sale price of $561.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $561.68 and the lowest price at which the shares were sold was $561.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $562.52 rounded to the nearest hundredth. The highest price at which the shares were sold was $562.86 and the lowest price at which the shares were sold was $562.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $563.62 rounded to the nearest hundredth. The highest price at which the shares were sold was $563.87 and the lowest price at which the shares were sold was $563.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $564.36 rounded to the nearest hundredth. The highest price at which the shares were sold was $564.97 and the lowest price at which the shares were sold was $564.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $565.31 rounded to the nearest hundredth. The highest price at which the shares were sold was $565.76 and the lowest price at which the shares were sold was $565.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
FAQ
What did the Northrop Grumman (NOC) director report in this Form 4?
The filing reports that a Northrop Grumman (NOC) director sold multiple small blocks of common stock in open-market transactions on 11/24/2025.
On what date did the reported Northrop Grumman (NOC) stock sales occur?
All of the reported transactions occurred on November 24, 2025, as shown in Table I of the Form 4.
Were the Northrop Grumman (NOC) insider sales made under a Rule 10b5-1 plan?
Yes. The explanation states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
Does this Form 4 involve any derivative securities of Northrop Grumman (NOC)?
No derivative transactions are reported. Table II for derivative securities is present but does not list any acquisitions or dispositions.
What role does the reporting person hold at Northrop Grumman (NOC)?
The reporting person is identified as a Director of Northrop Grumman Corporation, as indicated in the relationship section of the form.